Clinical Trial Update: ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ALA-mediated photodynamic therapy to vehicle PDT for actinic keratoses and reduction of new non-melanoma skin cancers in solid organ tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Non-melanoma Skin Cancer

Drugs mentioned

• ALA-PDT (5-aminolevulinic acid–mediated photodynamic therapy)
• Vehicle PDT

Snippet

Sponsor: DUSA Pharmaceuticals, Inc. | Conditions: Actinic Keratoses, Skin Neoplasms | Phase 2 | Status: TERMINATED